Dapagliflozin Matches Non-Loop Diuretic for AHF Congestion Dapagliflozin Matches Non-Loop Diuretic for AHF Congestion
The SGLT2 inhibitor didn ' t relieve congestion more effectively than a ' thiazide-like ' diuretic when added to furosemide in loop-diuretic –resistant patients with acute heart failure.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 6, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
Farxiga's Decongestion Flop; Benefit of Strong Legs; 2,500-Mile Heart Transport
(MedPage Today) -- Patients resistant to the loop diuretic furosemide did not find greater decongestive relief from dapagliflozin (Farxiga) than metolazone in a small trial. (European Heart Journal)
Longer time spent in body weight time in target... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 23, 2023 Category: Cardiology Source Type: news
Mortality Similar With Torsemide, Furosemide for Patients Hospitalized With Heart Failure
TUESDAY, Jan. 24, 2023 -- For patients hospitalized for heart failure, all-cause mortality does not differ significantly at 12 months for those receiving torsemide or furosemide, according to a study published in the Jan. 17 issue of the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 24, 2023 Category: Pharmaceuticals Source Type: news
Is There a Best Diuretic Drug for Heart Failure?
THURSDAY, Jan. 19, 2023 -- It doesn ’t matter which water pill you’re prescribed to treat your heart failure, because new trial data shows that one works as well as the other.
Two diuretics widely used to treat heart failure, furosemide and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 19, 2023 Category: General Medicine Source Type: news
Clarity on Loop Diuretic Choice in HF: TRANSFORM-HF Published Clarity on Loop Diuretic Choice in HF: TRANSFORM-HF Published
The trial blasts the common view that torsemide offers advantages over furosemide in heart failure, but its offbeat design raises caution about interpretation.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 18, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
Nov 11 2022 This Week in Cardiology Nov 11 2022 This Week in Cardiology
AHA 2022 Part 1: ISCHEMIA-EXTEND, STRONG-HF, chlorthalidone vs HCTZ, experts vs practitioners; torsemide vs furosemide; and TG lowering are discussed by John Mandrola, MD, in this week ’s podcast.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 11, 2022 Category: Cardiology Tags: Cardiology Commentary Source Type: news
No Survival Gain for Torsemide vs Furosemide in HF: TRANSFORM-HF No Survival Gain for Torsemide vs Furosemide in HF: TRANSFORM-HF
One loop diuretic is the most widely used in heart failure, the other may have advantages in some situations, but there ' s been no head-to-head comparison -- until now.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 5, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
Furosemide Holds Up to Newer, Stronger Loop Diuretic During HF Hospitalization
(MedPage Today) -- CHICAGO -- The choice between furosemide and torsemide didn't matter for longer-term clinical outcomes of hospitalized heart failure patients, according to the comparative effectiveness trial TRANSFORM-HF.
The incidence of... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 5, 2022 Category: Cardiology Source Type: news
FDA Approves Self-administered, SubQ Furosemide Preparation FDA Approves Self-administered, SubQ Furosemide Preparation
The preparation of the common loop diuretic is said to provide"intravenous-equivalent" dosing for outpatients with heart failure and volume overload.FDA Approvals (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 12, 2022 Category: Cardiology Tags: Cardiology News Alert Source Type: news
FDA Approves At-Home Furosemide for Heart Failure
(MedPage Today) -- The FDA approved the first furosemide (Furoscix) formulation for subcutaneous self-administration by patients with congestive heart failure, scPharmaceuticals announced.
The IV-equivalent formulation is indicated for the treatment... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - October 10, 2022 Category: Urology & Nephrology Source Type: news
FDA Approves Furoscix (furosemide injection) for the At-Home Treatment of Congestion Due to Fluid Overload in Chronic Heart Failure
Furoscix demonstrated 99.6% bioavailability and produced similar diuresis and natriuresis compared to intravenous furosemide
BURLINGTON, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 10, 2022 Category: Drugs & Pharmacology Source Type: news
High-Dose Loop Diuretic Can Raise Post-Cardiac Surgery Mortality High-Dose Loop Diuretic Can Raise Post-Cardiac Surgery Mortality
Furosemide at high doses after cardiac surgeries like valve replacement or coronary bypass can prolong ICU stays and worsen mortality, a cohort analysis suggests.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 26, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
furosemide
Title: furosemideCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 8/10/2022 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - August 10, 2022 Category: Cardiology Source Type: news
Furosemide Seen as Safe for Preventing Newborn Lung Disease Furosemide Seen as Safe for Preventing Newborn Lung Disease
Frequently used off-label, the drug was not riskier than placebo, a new study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 25, 2022 Category: Consumer Health News Tags: Pediatrics News Source Type: news
Palliative Care in Assisted Living
Mrs. M is a 92-year-old woman residing in an assisted living community. Her medical history includes hypertension, gout, hyperlipidemia, atrial fibrillation, hypothyroidism, and melanoma with invasion into the parotid gland; she has had removal of a lesion and a parotidectomy with nerve involvement impacting the 7th cranial nerve. Her medications include oral levothyroxine, 100 μg daily; oral vitamin D, 1,000 units daily; oral probenecid 500/colchicine, 0.5 mg daily; oral lisinopril, 5 mg daily; oral furosemide, 20 mg daily; oral duloxetine, 60 mg for depression; oral carvedilol, 6.25 mg twice a day; oral aspirin, 81 mg d...
Source: Caring for the Ages - March 29, 2022 Category: Health Management Authors: Barbara Resnick, Paige Hector Tags: Interdisciplinary Team Case Studies Source Type: news
